LogicBio Therapeutics (LOGC) Misses Q3 EPS by 4c
Tweet
Share
E-mailGet Alerts LOGC Hot Sheet
Price: $7.06 --0%
EPS Growth %: +42.9%
Financial Fact:
Cost of revenues: 241.9K
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +42.9%
Financial Fact:
Cost of revenues: 241.9K
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
LogicBio Therapeutics (NASDAQ: LOGC) reported Q3 EPS of ($0.04).
For earnings history and earnings-related data on LogicBio Therapeutics (LOGC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Concurrent Technologies (CNC:LN) PT Raised to GBP3.20 at Berenberg
- Geberit AG (GEBN:SW) (GBERY) PT Raised to CHF712 at Jefferies
- JPMorgan Downgrades Woolworths Holdings Ltd (WHL:SJ) to Underweight
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
